Nations Ponder Financial Incentives To Spur New Antibiotic Research, Development

The Lancet: Countries mull over incentives for developing antibiotics
“The prospect of slipping into a deadly, post-antibiotic era is prompting countries across the world to work out when and what they are willing to pay drug companies to develop desperately needed antibiotics. Governments have commissioned academics, economists, business analysts, and global health experts to scour the world for different financial incentive models…” (Anderson, 5/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.